HCPCS Level IIdrugActive
J3380
Inj vedolizumab iv 1 mg
BETOS: O1E
Effective: 2024-04-01
Referenced in 2 policies
Description
Injection, vedolizumab, intravenous, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Entyvio
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
1 MG
Billing Units
300.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.